Establishment and evaluation of extracellular vesicles from human blood and surgical resection of discarded liver tissue

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200055688

Enrollment

Unknown

Registered

2022-01-16

Start date

2022-01-31

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-alcoholic fatty liver

Interventions

non-alcoholic fatty liver disease group vs. non-NAFLD group:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hepatic hemangioma with or without NAFLD (diagnosed by liver surgeons according to the Guidelines for the Prevention and Treatment of Non-alcoholic Fatty Liver Disease (2018 Update) issued by the Hepatology Branch of the Chinese Medical Association), patients who had completed the relevant pre-operative examination and signed the consent for surgical treatment (this study did not add any additional examination other than diagnosis of hepatic hemangioma and related to surgery).

Exclusion criteria

Exclusion criteria: 1. Various types of diabetes; 2. Infectious diseases; 3. Blood system diseases; 4. Acute and chronic hepatitis other than NAFLD; 5. Acute and chronic pancreatitis; 6. Acute and chronic kidney disease; 7. Autoimmune diseases; 8. Malignant tumors; 9. Patients with previous acute cardiovascular and cerebrovascular events; 10. Patients who have recently (within 1 month) taken drugs that damage liver function (including statins); 11. Other special reasons are not suitable for participating in this research.

Design outcomes

Primary

Measure	Time frame
number of extracellular vesicles;	—

Countries

China

Contacts

Public ContactNanwei Tong

West China Hospital of Sichuan University

tongnw@scu.edu.cn+86 18980601196

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026